Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

(2011) R. J. Kelly et al.   BLOOD

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

(2011) Yuzuru Kanakura et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

(2010) Peter Hillmen et al.   AMERICAN JOURNAL OF HEMATOLOGY

Pulmonary hypertension and nitric oxide depletion in sickle cell disease

(2010) H. F. Bunn et al.   BLOOD

The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model

(2010) W. Hu et al.   BLOOD

Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

(2010) Anita Hill et al.   BRITISH JOURNAL OF HAEMATOLOGY

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

(2008) R. P. de Latour et al.   BLOOD